quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:38:03·49d
ANALYSTRating
ALX Oncology Holdings Inc. logo

UBS resumed coverage on ALX Oncology with a new price target

ALXO· ALX Oncology Holdings Inc.
Health Care
Original source

Companies

  • ALXO
    ALX Oncology Holdings Inc.
    Health Care

Recent analyst ratings

  • Mar 19UpdateWells Fargo$5.00
  • Mar 6UpdateUBS$6.00
  • Nov 13UpdateJefferies$4.00
  • Mar 6UpdateJefferies$3.00
  • Dec 19UpdateJefferies$2.00
  • Mar 8UpdateStifel$14.00

Related

  • SEC3d
    SEC Form DEF 14A filed by ALX Oncology Holdings Inc.
  • INSIDER6d
    SEC Form 4 filed by Knight Jeff E.
  • INSIDER6d
    SEC Form 4 filed by Klencke Barbara
  • INSIDER6d
    SEC Form 3 filed by new insider Knight Jeff E.
  • PR6d
    ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
  • SEC11d
    ALX Oncology Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR11d
    ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
  • INSIDER31d
    SEC Form 4 filed by Pinto Shelly
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022